Background Since the beginning of the coronavirus disease 2019 (COVID-19) epidemic,
misinformation has been spreading uninhibited over traditional and social media at a rapid …

Diversity of the gut microbiome is associated with higher response rates for cancer patients
receiving immunotherapy but has not been investigated in patients receiving radiation …

Tumor microbiota can produce active metabolites that affect cancer and immune cell signaling,
metabolism, and proliferation. Here, we explore tumor and gut microbiome features that …

High-quality evidence generated by appropriately powered and controlled trials is needed
to advance care for patients with coronavirus disease 2019 (COVID-19) and those who are …

Although high-risk human papillomavirus infection is a well-established risk factor for cervical
cancer, other co-factors within the local microenvironment may play an important role in …

Background A diverse and abundant gut microbiome can improve cancer patients’ treatment
response; however, the effect of pelvic chemoradiotherapy (CRT) on gut diversity and …

Background Squamous cell carcinoma of the anus (SCCA) is a rare gastrointestinal cancer.
Factors associated with progression of HPV infection to anal dysplasia and cancer are …

… Author links open overlay panel Greyson Biegert a 1 , Molly B. El Alam a 1 , Tatiana Karpinets
b , Xiaogang Wu b , Travis T. Sims c , Kyoko Yoshida-Court a , Erica J. Lynn a , Jingyan …

Simple Summary Cancer therapies should improve patient survival or at least improve the
quality of their life as they receive treatment for their disease. This is particularly important in …

3. Tang N, Li D, Wang X, Sun Z. Abnormal coagulation parameters are associated with poor
prognosis in patients with novel coronavirus pneumonia. J Thromb Haemost. 2020; 18 (4): …